STATE Uncategorised Japan grants priority review status to Alzheimer’s treatment from Eisai-Biogen The Bengaluru Live 30 January 2023 1 minute read 0 📘 Read this story in KannadaJapanese drugmaker Eisai Co Ltd and Biogen Inc said on Sunday the Japanese Ministry of Health, Labour and Welfare has given priority review for their Alzheimer’s disease drug. About the Author The Bengaluru Live Administrator Published In Public Interest by thebengalurulive.com View All Posts Post navigation Previous: Handball-Denmark beat France to historic third handball world titleNext: NFL-Eagles thrash 49ers to reach Super Bowl Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related Stories STATE Supreme Court Dismisses Tamil Nadu Plea on Mekedatu Project; DK Shivakumar Calls It ‘Good News’ for Karnataka Satya Prakash Chaubey 26 May 2026 STATE Monsoon Likely to Arrive Early in India as Heatwave Intensifies Across North; IMD Predicts Kerala Entry by May 26 The Bengaluru Live 19 May 2026 STATE Bengaluru Karnataka Bus Strike Called Off for Now After High Court Intervention; Government Told to Hold Talks With Transport Workers The Bengaluru Live 19 May 2026
